Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cardiotoxicity × Docetaxel × Clear all

Phase

Status

Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 242 Carcinoma, Non-Small-Cell Lung 174 Prostatic Neoplasms 144 Lung Neoplasms 78 Stomach Neoplasms 59 Neoplasms 58 Squamous Cell Carcinoma of Head and Neck 47 Head and Neck Neoplasms 47 Esophageal Neoplasms 43 Neoplasm Metastasis 39 Ovarian Neoplasms 33 Pancreatic Neoplasms 25 Sarcoma 19 Urinary Bladder Neoplasms 16 Carcinoma, Ovarian Epithelial 16 Breast Neoplasms, Male 16 Adenocarcinoma Of Esophagus 15 Unspecified Adult Solid Tumor, Protocol Specific 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Esophageal Squamous Cell Carcinoma 12 Carcinoma, Squamous Cell 12 Adenocarcinoma of Lung 12 Fallopian Tube Neoplasms 11 Melanoma 10 Adenocarcinoma 10 Triple Negative Breast Neoplasms 9 Inflammatory Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma 8

Interventions

Doxorubicin 11 Razoxane 5 Dexrazoxane 5 Echocardiography 4 Cyclophosphamide 4 Vincristine 3 Trastuzumab 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Etoposide 3 Electrocardiography 3 Radiotherapy 2 Prednisone 2 Methotrexate 2 Magnetic Resonance Spectroscopy 2 Exercise 2 Carvedilol 2 Bleomycin 2 salicylhydroxamic acid 1 oblimersen 1 hydrocortisone hemisuccinate 1 Vascular Stiffness 1 VAP-cyclo protocol 1 Tablets 1 Silymarin 1 Reverse Transcriptase Polymerase Chain Reaction 1 Resistance Training 1 Pulse Wave Analysis 1 Palliative Care 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00377559 2015-10-06

MYOTAX

Catharina Ziekenhuis Eindhoven

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡